Physician views on lung cancer screening using low-dose computed tomography (LDCT) are limited. Primary care providers (PCPs) and specialists were surveyed about their knowledge and attitudes toward lung cancer screening and likelihood to order LDCT screening. Despite feeling less confident and knowledgeable about screening, PCPs are equally likely to recommend LDCT screening. Further education about LDCT screening could strengthen lung cancer screening programs. Background: On the basis of the results of the National Lung Screening Trial, the US Preventive Services Task Force now recommends yearly low-dose computed tomography (LDCT) for lung cancer screening among high-risk individuals. There is limited information regarding physician attitudes toward LDCT screening and whether these vary according to provider specialty. Materials and Methods: Primary care providers (PCPs) and specialists were surveyed about their knowledge and attitudes toward lung cancer screening and likelihood to order an LDCT screening. Descriptive and univariate analyses were used to assess differences between PCPs versus specialists. Results: Of the 103 respondents 69% were PCPs, 45% were attending-level physicians, 42% were male, and most (51%) worked in mixed outpatient/inpatient practice settings. Compared with specialists, PCPs were less likely to feel confident in their ability to identify appropriate patients for lung cancer screening (63.8% vs. 93.5%; P < .01) or to decide the workup of patients with positive LDCT findings (52.9% vs. 93.5%; P < .01). PCPs were also less likely to believe that the recommended yearly screening interval is feasible (27.5% vs. 86.7%; P < .01), to feel comfortable counseling patients on LDCT (51.4% vs. 82.8%; P ¼ .01) or have sufficient time for counseling (14.3% vs. 50%; P < .01). Despite these differences, PCPs were equally as likely as specialists to recommend LDCT for their high-risk smokers. Conclusion: Despite feeling less confident and knowledgeable about lung cancer screening, PCPs are as likely as specialists to recommend LDCT screening. However, PCPs need further education to ensure the success of lung cancer screening programs.
Introduction
Lung cancer is the leading cause of cancer death in the United States. 1 Lung cancer deaths each year are greater than colon, breast, and prostate cancer combined. 2 As of 2011, lung cancer made up 14% of all cancer diagnoses and 27% of all cancer deaths in the United States. 1 The incidence of lung cancer in the United States for 2016 was estimated to be 224,000 cases with men having a greater incidence than women and approximately 2 of 3 people diagnosed being older than the age of 65 years. 2 Reduction in the lung cancer death rate is a component of the Healthy People 2020 objectives whose goal is to reduce the lung cancer death rate by 10% from a 2007 baseline of 50.6 lung cancer deaths per 100,000 (after age adjustment) to 45.5 deaths per 100,000. 3 Reduction in lung cancer mortality rates can be achieved through screening with low-dose computed tomography (LDCT) and detection of early-stage lung cancer. The National Lung Screening Trial (NLST) showed a 20% decrease in lung cancer-specific mortality and 7% reduction in overall mortality among high-risk smokers who received LDCT screening versus standard chest x-rays. 4 This reduction in lung cancer-specific and overall mortality 1 is the basis for current guidelines by professional societies such as the American Cancer Society, the National Cancer Comprehensive Care Network, and the American College of Chest Physicians recommending annual LDCT screening for patients 55 to 74 years of age with at least a 30 pack-year smoking history who are current smokers (or former smokers who quit within the past 15 years). [5] [6] [7] The US Preventive Services Task Force (USPSTF) issued a grade B recommendation for annual LDCT screening for lung cancer for adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. 8 This recommendation applies to approximately 8.7 million people in the United States, and its implementation could lead to the avoidance of as many as 12,000 lung cancer-associated deaths. 9, 10 The Centers for Medicare and Medicaid Services (CMS) as well as the Affordable Care Act provide coverage for lung cancer screening, 11 but this coverage requires that patients receive counseling regarding lung cancer screening in a shared decision-making visit and must include the use of patient decision aids as well as a written referral order from a qualified provider. These requirements for shared decisionmaking place primary care providers (PCPs) at the forefront of the implementation and success of lung cancer screening programs.
There is however limited information regarding PCPs' views on lung cancer screening using LDCT. We undertook this study to assess the knowledge and attitudes of PCPs versus specialists (oncologists, pulmonologists, radiologists) toward lung cancer screening using LDCT as well as their likelihood to recommend LDCT screening.
Materials and Methods

Questionnaire Development
A multidisciplinary focus group comprised of 12 physicians (5 house staff or fellows and 7 attendings) from oncology (2), primary care (8), pulmonology (1) and radiology (1) was conducted to inform design of the questionnaire survey. Findings from the focus group were used to develop an anonymous self-administered questionnaire to assess the knowledge of and attitudes and behavior toward lung cancer screening by PCPs (internal medicine and geriatrics) and specialists (oncologists, pulmonologists, radiologists) practicing at a large academic medical center in New York City.
Questionnaire Domains
The questionnaire focused on 3 domains: knowledge and familiarity with lung cancer screening recommendations, attitudes about LDCT screening, and anticipated behavior regarding recommending and ordering LDCT screening for high-risk smokers (see Appendix A). Questions with a focus on knowledge and attitudes were multiple-choice and scored on a 4-point Likert scale. Familiarity with the USPSTF lung cancer screening guidelines was used to measure knowledge. Attitudes toward LDCT screening were captured through questions with a focus on comfort with counseling about LDCT screening and management of positive results and concerns about costs, access to screening, and consequences of screening. Behavior was evaluated by questions used to assess a provider's likelihood to order LDCT screening for high-risk patients in the next year. The questionnaire was piloted with 3 providers in primary care and pulmonology and revised on the basis of their recommendations before its administration.
Participants
The survey was distributed to physicians in internal medicine and geriatrics at Mount Sinai Medical Center in New York City via a secure Web-based survey capture platform (REDCap) and on paper during conferences, individual, and large group meetings as well as general internal medicine, oncology, pulmonary, and radiology grand rounds. Demographic information collected included age, gender, practice specialty, level of training, and practice setting. Surveys were distributed between October and December 2014. The study was exempt by the Institutional Review Board at Icahn School of Medicine at Mount Sinai with waiver of signed consent.
Statistical Methods c
2 Analysis was used to assess differences in attitudes and behaviors about lung cancer screening between PCPs and specialists. Multivariate logistic regression analysis was performed to assess factors associated with likelihood to order a screening LDCT scan in the next year for high-risk smokers, controlling for gender, level of training, and specialty. All statistical analyses were performed using SPSS version 20 (IBM Corp) with a significance level of .05.
Results
Participants
A total of 103 physicians participated in the study (Table 1) . Most were between the ages of 25 and 34 years (57.4%) and female (57.8%). More than two-thirds (69.3%) were PCPs, 19.8% were pulmonologists, and 9.9% were oncologists. Approximately half (55.4%) were interns, residents, or fellows, and 45.6% were attending-level providers. Most practiced in a mixed practice setting that included inpatient as well as outpatient care. Lung Cancer Screening: PCP Versus Specialists
Attitudes Regarding Lung Cancer Screening
Compared with specialists, PCPs felt less comfortable in their ability to identify appropriate patients for lung cancer screening (63.8% vs. 93.5%; P < .01) and were more confused about how to apply lung cancer screening guidelines for patients who have multiple comorbidities (63.8% vs. 35.5%; P ¼ .01; Table 2 ). PCPs also felt less at ease counseling patients about LDCT screening (51.4% vs. 82.8%; P ¼ .01) and were not as confident in their abilities to decide on an appropriate workup of patients with positive computed tomography (CT) findings (52.9% vs. 93.5%; P < .01). PCPs were also less likely to believe that the recommended yearly screening interval was feasible (27.5% vs. 86.7%; P < .01), cost effective (8.6% vs. 29%; P ¼ .01), or that they would have sufficient time to counsel patients about CT scan screening (40.3% vs. 50%; P < .01). However, specialists as well as PCPs shared similar views about false positive results causing distress to patients (96.8% vs. 100%; P ¼ .31), worrying about incidental findings with LDCT screening (83.9% vs. 90%; P ¼ .51), and worrying about follow-up procedures associated with false positive results (83.9% vs. 90%; P ¼ .51).
Attitudes about lung cancer screening were not associated with gender except for physician worry about incidental findings with chest CT screenings (P ¼ .05) and physician concern over not being able to order chest CT screening for lung cancer because of insurance (P ¼ .024). In both instances, women were more likely to be worried than men (94.9% vs. 79.1% and 89.8% vs. 66.7%, respectively). The attitudes about lung cancer screening were also not associated with level of training except for the ability to identify appropriate patients for lung cancer screening (P ¼ .01) and feeling comfortable counseling patients about CT scan screening (P ¼ .03). House staff felt less confident and less comfortable than attendings (38% vs. 35% and 31% vs. 28%, respectively).
Characteristics Associated With Screening Behavior
Specialists as well as PCPs were equally likely to order an LDCT screen for eligible patients in the next year (84% vs. 81%; P ¼ .51, Table 3 ). Familiarity with the USPSTF lung cancer screening guidelines and ability to identify appropriate patients for screening were both associated with a physician's likelihood to order a screening LDCT for eligible patients in the next year (67.1% and 80.7%). In addition, being comfortable with counseling about screening for lung cancer and having sufficient time to counsel about LDCT screening were associated with likelihood to order LDCT (67.5% vs. 23.5%; P ¼ .01 and 28.9% vs. 5.6%; P ¼ .04, (Table 4) . Conversely, physicians who did not think it was cost effective to screen were less likely to order LDCT screening (OR, 0.09; 95% CI, 0.02-0.53).
Discussion
We found that compared with specialists, PCPs were less likely to feel confident identifying appropriate patients for LDCT screening or working up positive findings, less comfortable counseling patients about screening, and less likely to feel they have sufficient time for counseling. Despite these differences, PCPs and specialists in our sample were equally likely to recommend LDCT scans for lung cancer screening. This discordance could be because most physicians try to follow USPSTF guidelines, which recommend LDCT screening. The most significant barriers for PCPs to recommend lung cancer screening include counseling time and the yearly screening interval, both of which play a role in the implementation and success of screening programs.
Similar to the study by Hoffman et al of PCPs in New Mexico, 12 we found that cost and feasibility of LDCT screening to be of primary concern to PCPs. Providers in both studies believed that time limitations and the complexity of counseling required to explain LDCT screening as well as following up results would be barriers to the success of a screening program. Cost of screening using LDCT was also of concern among specialists in our study. Similarly, Iaccarino et al reported that pulmonologists were concerned about cost in addition to insufficient infrastructure and staffing. 13 Cost might now be less of a barrier for PCPs as well as specialists because the Affordable Care Act and CMS provide coverage for LDCT screening for high-risk patients. We found that specialists and PCPs shared similar views regarding false positive results and patient distress, the follow-up procedures associated with false positive results, and incidental findings using LDCT in lung cancer screening. Similar concerns such as the management of false positive results associated with mammography have been noted in breast cancer screening literature. Smith et al reported that the reasons physicians did not offer screening mammography specifically in women aged 40 to 49 years included concerns that patient harms such as increased anxiety, a high false positive rate, and overtreatment of benign findings outweighed the benefits. 14 The importance of physician recommendation practices for cancer screening and its subsequent uptake has been well documented in the literature. O'Malley et al 15 reported that the factor most strongly associated with mammography utilization for breast cancer screening was a physician's recommendation whereas Wee et al 16 suggested that a physician's recommendation also played a significant role in the completion of colorectal cancer screening. Patients' behavior toward screening is thus strongly influenced by physician recommendations. 17 Among smokers, a physician recommendation for LDCT to screen for lung cancer was an important factor for patients deciding whether they would undergo LDCT screening. 18 We found that PCPs were less comfortable in their ability to identify appropriate patients and to counsel about the use of LDCT screening, thus provider's recognition and confidence in these matters are required for lung cancer screening programs to be successful. Our study suggests a need for education about lung cancer screening guidelines, particularly for PCPs. Other studies have shown that that some PCPs believe that lung cancer screening is not as efficacious as other cancer screening programs such as those for breast or colorectal cancer. 19, 20 However on the basis of NLST data, 1 lung cancer death is prevented with every 320 people screened. 4 This is approximately equivalent to other cancer screening tests, thus indicating a need for more education among PCPs about the efficacy of lung cancer screening. 21 By increasing physicians' knowledge, familiarity with as well as confidence in counseling about lung cancer screening could subsequently increase. On the basis of our findings, we recommend that education about lung cancer screening should address the ability to identify appropriate patients or eligibility criteria for LDCT, insurance coverage, and management of positive results. Providing decision-making aids such as those recently developed by the Agency for Healthcare Research and Quality might assist PCPs in counseling about LDCT screening and might increase provider comfort and knowledge. Further development of clinical tools for providers regarding the workup of positive findings on LDCT might also help improve provider comfort and knowledge. This study, to our knowledge, is among the first to compare PCP and specialists' attitudes and behaviors toward lung cancer screening using LDCT. There are several limitations to this study. First, our surveys were administered before CMS's approval of coverage for LDCT for lung cancer screening. Our results might be different now that cost might no longer be as significant a factor in determining providers' behaviors and recommendations regarding LDCT screening. Furthermore, our sample size was modest and we conducted our study at a single urban, academic medical center, which might limit the generalizability of our results to other providers and practices, particularly those in community settings. Lung cancer screening programs often include tobacco cessation counseling for those who still smoke, but our study did not include questions regarding whether patients were counseled on tobacco cessation methods and how confident providers felt in providing this counseling. This information might have elucidated additional needs for provider education. Last, addressing smoking and lung cancer risks with patients might be affected by a clinician's personal bias and/or previous patient experiences, but we did not ask about respondents' personal or family history with smoking or lung 
Conclusion
Our study adds to the literature by showing similarities and differences between PCPs and specialists regarding their attitudes toward lung cancer screening using LDCT. Despite several differences in comfort with counseling and attitudes toward screening, PCPs as well as specialists were equally likely to order LDCT for lung cancer screening for high-risk patients. As implementation of lung cancer screening programs become more commonplace, further studies assessing provider attitudes and barriers to screening would shed light on the limitations of the NLST trial on which lung cancer screening recommendations are largely based. Additional work to increase provider knowledge about lung cancer screening, particularly for PCPs, and to identify the benefits or challenges of using shared decision-making tools when counseling about LDCT screening need to be undertaken to assess the effect of these interventions on provider behavior and ordering patterns for lung cancer screening.
Clinical Practice Points
There is limited information regarding PCPs' views on lung cancer screening using LDCT. Despite feeling less confident and knowledgeable about lung cancer screening, PCPs are as likely as specialists to recommend LDCT. Primary care providers are at the forefront of the implementation and success of lung cancer screening programs, and need further education to ensure their success.
